Bogart Wealth LLC’s iRadimed IRMD Stock Holding History

Bogart Wealth LLC’s Portfolio IRMD Stock Details IRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-25	Closed	-$1K	–	1125
2022 Q3	$1K	Buy	+25	New	+$871	﹤0.01%	906

Other funds holding IRMD

NTCM

Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RCMC

RK Capital Management (Colorado) Denver, Colorado $324K AUM 47.52% 1-Year Est. Return

BCM

Bares Capital Management Austin, Texas $1.08B AUM 38.13% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Bogart Wealth LLC's IRMD Position: Q4 2022 in Review

Bogart Wealth LLC sold out of iRadimed (IRMD) in Q4 2022, closing a stake of 25 shares — an estimated $1K sold.

Bogart Wealth LLC first reported a position in IRMD in Q3 2022 and held it in 1 quarter. The position peaked at $1K in Q3 2022. 79 funds tracked by Wall St. Rank hold IRMD as of Q4 2022.

Bogart Wealth LLC reported no remaining iRadimed position as of Q4 2022 after selling out during the quarter.
Bogart Wealth LLC sold 25 iRadimed shares in Q4 2022, an estimated $1K.
Bogart Wealth LLC first reported a position in iRadimed in Q3 2022 and held it in 1 quarter.
Bogart Wealth LLC's iRadimed position peaked at $1K in Q3 2022.
79 funds tracked by Wall St. Rank held iRadimed as of Q4 2022.

Based on Bogart Wealth LLC's 13F filing for Q4 2022, filed 6 Feb 2023.